Glenmark to set up plant in USIllustrative image – not actual.

Glenmark Pharmaceuticals will set up a new injectable facility in the US. The move has been taken to consolidate its presence in the country. The total investment for the facility is expected to be Rs 160 crore.


The new manufacturing facility will be added to the plant at Monroe, in North Carolina, the construction of which was started in August 2014.


After commissioning, the facility is expected to have a capacity to produce 300-400 million tablets and capsules per annum. The proposed injectable unit is expected to have a capacity of 20-25 million vials and pre-filled syringes per annum on commencement of production.


The company’s first manufacturing facility in North America is expected to commence production by the end of this year. The facility is spread across 1,00,000 sq ft and has been designed for manufacturing oral solids and injectables.


Glenmark presently has 14 manufacturing plants in four countries — India, Brazil, Argentina and the Czech Republic.

← All latest storiesBack to top →